Rare Malignant Tumors of the Breast

por Miller, Trevor, Albarracin, Constance, Carkaci, Selin, Whitman, Gary J, Adrada, Beatriz E
Publicado 2015

Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer

por Bhardwaj, Anjana, Embury, Matthew D., Rojo, Raniv D., Albarracin, Constance, Bedrosian, Isabelle
Publicado 2021

Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database

por Wang, Jun, Wei, Bing, Albarracin, Constance T, Hu, Jianhua, Abraham, Susan C, Wu, Yun
Publicado 2014

The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer

por Bhardwaj, Anjana, Singh, Harpreet, Trinidad, Celestine Marie, Albarracin, Constance T., Hunt, Kelly K., Bedrosian, Isabelle
Publicado 2018

Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling

por Bhardwaj, Anjana, Ganesan, Nivetha, Tachibana, Kazunoshin, Rajapakshe, Kimal, Albarracin, Constance T., Gunaratne, Preethi H., Coarfa, Cristian, Bedrosian, Isabelle
Publicado 2015

Suppression of Akt-mTOR Pathway-A Novel Component of Oncogene Induced DNA Damage Response Barrier in Breast Tumorigenesis

por Bhardwaj, Anjana, Rosen, Daniel, Liu, Mei, Liu, Yan, Hao, Qiang, Ganesan, Nivetha, Etzel, Carol J., Gullett, Ashley, Albarracin, Constance T., Bedrosian, Isabelle
Publicado 2014

Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence

por Caruso, Joseph A, Karakas, Cansu, Zhang, Jing, Yi, Min, Albarracin, Constance, Sahin, Aysegul, Bondy, Melissa, Liu, Jinsong, Hunt, Kelly K, Keyomarsi, Khandan
Publicado 2014

Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence

por Caruso, Joseph A, Karakas, Cansu, Zhang, Jing, Yi, Min, Albarracin, Constance, Sahin, Aysegul, Bondy, Melissa, Liu, Jinsong, Hunt, Kelly K., Keyomarsi, Khandan
Publicado 2015

Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration

por Chen, Xian, Yang, Dong, Carey, Jason P. W., Karakas, Cansu, Albarracin, Constance, Sahin, Aysegul A., Arun, Banu K., Guray Durak, Merih, Li, Mi, Kohansal, Mehrnoosh, Bui, Tuyen N., Ha, Min-Jin, Hunt, Kelly K., Keyomarsi, Khandan
Publicado 2021

Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer

por Mistretta, Brandon, Rankothgedera, Sakuni, Castillo, Micah, Rao, Mitchell, Holloway, Kimberly, Bhardwaj, Anjana, El Noafal, Maha, Albarracin, Constance, El-Zein, Randa, Rezaei, Hengameh, Su, Xiaoping, Akbani, Rehan, Shao, Xiaoshan M., Czerniecki, Brian J., Karchin, Rachel, Bedrosian, Isabelle, Gunaratne, Preethi H.
Publicado 2023

DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes

por Kuerer, Henry M., Smith, Benjamin D., Chavez-MacGregor, Mariana, Albarracin, Constance, Barcenas, Carlos H., Santiago, Lumarie, Edgerton, Mary E., Rauch, Gaiane M., Giordano, Sharon H., Sahin, Aysegul, Krishnamurthy, Savitri, Woodward, Wendy, Tripathy, Debasish, Yang, Wei T., Hunt, Kelly K.
Publicado 2017

Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray

por Chen, Hui, Singh, Rajesh R., Lu, Xinyan, Huo, Lei, Yao, Hui, Aldape, Kenneth, Abraham, Ronald, Virani, Shumaila, Mehrotra, Meenakshi, Mishra, Bal Mukund, Bousamra, Alex, Albarracin, Constance, Wu, Yun, Roy-Chowdhuri, Sinchita, Shamanna, Rashmi Kanagal, Routbort, Mark J., Medeiros, L. Jeffrey, Patel, Keyur P., Broaddus, Russell, Sahin, Aysegul, Luthra, Rajyalakshmi
Publicado 2017